Can Hypofractionation and Immune Modulation Coexist?

The past few years have seen a renewed interest in bladder-preserving treatment for patients with muscle-invasive bladder cancer (MIBC). Although there is no doubt that bladder preservation is an excellent local treatment with high levels of control and low levels of late toxicity,1 about half of patients will die of metastatic disease within 5 years. At the heart of this strategy is radical trimodality treatment (TMT), comprising tumor resection followed by radiation therapy with a radiosensitizer.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Editorial Source Type: research